Suchergebnisse - "Buti, Maria"

PubPharm (10)

1

JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analog suppressed patients with chronic hepatitis B : REEF-2

enthalten in: Journal of hepatology | 2024

von Agarwal, K. | Buti, M. | van Bömmel, F. | +14

2

Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs

enthalten in: The Kaohsiung journal of medical sciences | 2024

von Jang, T. | Liang, P. | Jun, D. | +40

3

Integrating viral hepatitis management into the emergency department : A further step towards viral hepatitis elimination

enthalten in: JHEP reports : innovation in hepatology | 2024

von Llaneras, J. | Ruiz-Cobo, J. | Rando-Segura, A. | +16

4

Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D : Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference

enthalten in: Journal of hepatology | 2023

von Ghany, M. | Buti, M. | Lampertico, P. | +2

5

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers

enthalten in: JHEP reports : innovation in hepatology | 2023

von Roade, L. | Riveiro-Barciela, M. | Pfefferkorn, M. | +11

6

Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells

enthalten in: JHEP reports : innovation in hepatology | 2023

von Aggarwal, A. | Odorizzi, P. | Brodbeck, J. | +15

7

Standardized Hepatitis B Virus RNA Quantification in Untreated and Treated Chronic Patients : a Promising Marker of Infection Follow-Up

enthalten in: Microbiology spectrum | 2022

von Cortese, M. | Riveiro-Barciela, M. | Tabernero, D. | +16

8

An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B

enthalten in: Journal of hepatology | 2022

von Kim, H. | Lampertico, P. | Nam, J. | +33

9

Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2020

von Roade, L. | Loglio, A. | Borghi, M. | +9

10

GEHEP 010 study : Prevalence and distribution of hepatitis B virus genotypes in Spain (2000-2016)

enthalten in: The Journal of infection | 2020

von Aguilera, A. | Trastoy, R. | Rodríguez-Frias, F. | +21

1
[1]